Metaxalone 800 MG Oral Tablet — RxCUI 351254
RxNorm drug concept · Semantic clinical drug
RxCUI 351254
Semantic clinical drug · SCD
● Current RxNorm concept 53 FDA products
178 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI351254
Official nameMetaxalone 800 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped53
Package NDCs mapped178
Reported Medicaid activity (SDUD)20,975 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Metaxalone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Metaxalone is a muscle relaxant used to help ease pain and discomfort from short-term musculoskeletal conditions — things like muscle strains or injuries. It's not meant to be used...
- Drowsiness is one of the most common side effects, yes. Dizziness, headache, and feeling irritable or nervous can also happen. You should not drive, operate heavy machinery, or do...
- Will metaxalone make me too drowsy to function?
- It does matter — and you should be consistent. Taking metaxalone with a high-fat meal significantly increases the amount of drug absorbed into your body compared to taking it on an...
🕸️ Concept Web — How Metaxalone 800 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Metaxalone 800 MG Oral Tablet
RxCUI 351254 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Metaxalone
59078IN
-
Metaxalone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Skelaxin
204315BN
-
Skelaxin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Metaxalone Oral Tablet
372801SCDF -
Metaxalone Oral Product
1156711SCDG -
Metaxalone Pill
1156712SCDG -
Metaxalone Oral Tablet [Skelaxin]
368570SBDF -
Skelaxin Oral Product
1183739SBDG -
Skelaxin Pill
1183740SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Metaxalone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Metaxalone 800 MG
353385SCDC -
Metaxalone 800 MG Oral Tablet [Skelaxin]
352277SBD -
Metaxalone 800 MG [Skelaxin]
575975SBDC
-
Metaxalone 800 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Metaxalone 800 MG
SCDC · 353385 -
Metaxalone Oral Tablet
SCDF · 372801 -
Metaxalone Oral Product
SCDG · 1156711 -
Metaxalone Pill
SCDG · 1156712
Brand-Name Concepts
-
Metaxalone 800 MG Oral Tablet [Skelaxin]
SBD · 352277 -
Metaxalone 800 MG [Skelaxin]
SBDC · 575975 -
Metaxalone Oral Tablet [Skelaxin]
SBDF · 368570 -
Skelaxin Oral Product
SBDG · 1183739 -
Skelaxin Pill
SBDG · 1183740 -
Skelaxin
BN · 204315
📦 FDA Products & Package NDCs
53 products · 178 package NDCs
178 package NDCs map to RxCUI 351254 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 80425-0524-03 | 90 TABLET in 1 BOTTLE (80425-0524-3) | Metaxalone | Advanced Rx of Tennessee, LLC | 2025-05-29 |
| 80425-0580-01 | 30 TABLET in 1 BOTTLE (80425-0580-1) | Metaxalone | Advanced Rx of Tennessee, LLC | 2026-04-17 |
| 80425-0580-02 | 60 TABLET in 1 BOTTLE (80425-0580-2) | Metaxalone | Advanced Rx of Tennessee, LLC | 2026-04-17 |
| 80425-0580-03 | 90 TABLET in 1 BOTTLE (80425-0580-3) | Metaxalone | Advanced Rx of Tennessee, LLC | 2026-04-17 |
| 85509-1435-01 | 120 TABLET in 1 BOTTLE (85509-1435-1) | Metaxalone | PHOENIX RX LLC | 2025-10-16 |
| 85509-1435-03 | 30 TABLET in 1 BOTTLE (85509-1435-3) | Metaxalone | PHOENIX RX LLC | 2025-10-16 |
| 85509-1435-06 | 60 TABLET in 1 BOTTLE (85509-1435-6) | Metaxalone | PHOENIX RX LLC | 2025-10-16 |
| 85509-1435-09 | 90 TABLET in 1 BOTTLE (85509-1435-9) | Metaxalone | PHOENIX RX LLC | 2025-10-16 |
| 85509-2341-01 | 100 TABLET in 1 BOTTLE (85509-2341-1) | Metaxalone | PHOENIX RX LLC | 2025-07-31 |
| 85509-2341-02 | 120 TABLET in 1 BOTTLE (85509-2341-2) | Metaxalone | PHOENIX RX LLC | 2025-07-31 |
| 85509-2341-03 | 30 TABLET in 1 BOTTLE (85509-2341-3) | Metaxalone | PHOENIX RX LLC | 2025-07-31 |
| 85509-2341-06 | 60 TABLET in 1 BOTTLE (85509-2341-6) | Metaxalone | PHOENIX RX LLC | 2025-07-31 |
| 85509-2341-09 | 90 TABLET in 1 BOTTLE (85509-2341-9) | Metaxalone | PHOENIX RX LLC | 2025-07-31 |
| 85766-0011-01 | 100 TABLET in 1 BOTTLE (85766-011-01) | Metaxalone | Sportpharm LLC | 2025-06-19 |
| 85766-0011-12 | 12 TABLET in 1 BOTTLE (85766-011-12) | Metaxalone | Sportpharm LLC | 2025-06-19 |
| 85766-0011-15 | 15 TABLET in 1 BOTTLE (85766-011-15) | Metaxalone | Sportpharm LLC | 2025-06-19 |
| 85766-0011-20 | 20 TABLET in 1 BOTTLE (85766-011-20) | Metaxalone | Sportpharm LLC | 2025-06-19 |
| 85766-0011-30 | 30 TABLET in 1 BOTTLE (85766-011-30) | Metaxalone | Sportpharm LLC | 2025-06-19 |
| 85766-0011-60 | 60 TABLET in 1 BOTTLE (85766-011-60) | Metaxalone | Sportpharm LLC | 2025-06-19 |
| 85766-0011-90 | 90 TABLET in 1 BOTTLE (85766-011-90) | Metaxalone | Sportpharm LLC | 2025-06-19 |
| 85766-0143-01 | 100 TABLET in 1 BOTTLE (85766-143-01) | Metaxalone | Sportpharm LLC | 2026-02-03 |
| 85766-0143-06 | 6 TABLET in 1 BOTTLE (85766-143-06) | Metaxalone | Sportpharm LLC | 2026-04-05 |
| 85766-0143-12 | 12 TABLET in 1 BOTTLE (85766-143-12) | Metaxalone | Sportpharm LLC | 2026-03-11 |
| 85766-0143-15 | 15 TABLET in 1 BOTTLE (85766-143-15) | Metaxalone | Sportpharm LLC | 2026-03-11 |
| 85766-0143-20 | 20 TABLET in 1 BOTTLE (85766-143-20) | Metaxalone | Sportpharm LLC | 2026-03-11 |
| 85766-0143-30 | 30 TABLET in 1 BOTTLE (85766-143-30) | Metaxalone | Sportpharm LLC | 2026-02-03 |
| 85766-0143-60 | 60 TABLET in 1 BOTTLE (85766-143-60) | Metaxalone | Sportpharm LLC | 2026-02-03 |
| 85766-0143-90 | 90 TABLET in 1 BOTTLE (85766-143-90) | Metaxalone | Sportpharm LLC | 2026-02-03 |
Observed labelers:
Bryant Ranch Prepack (38) ·
Proficient Rx LP (17) ·
Sportpharm LLC (15) ·
Asclemed USA, Inc. (11) ·
Doc Rx (10) ·
PHOENIX RX LLC (9)
· +23 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.